Association between plasma endocannabinoids and appetite in hemodialysis patients: A pilot study

Nutrition Research

Volumn 36, Issue 7, 2016, Pages 658-662

  Friedman, Allon N ^a   Kim, Jeffrey ^b   Kaiser, Shaun ^c   Pedersen, Theresa L ^d   Newman, John W ^b,d   Watkins, Bruce A ^b,e  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Texas Kidney Institute   (United States)

^d U S DEPARTMENT OF AGRICULTURE   (United States)

^e UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Endocannabinoids; Hemodialysis; Mass spectrometry; Omega 3; Omega 6; Polyunsaturated fatty acids

Indexed keywords

ALPHA LINOLEOYL ETHANOLAMIDE; ARACHIDONIC ACID; ARACHIDONOYL ETHANOLAMIDE; DIHOMO GAMMA LINOLENOYL ETHANOLAMIDE; DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOYL ETHANOLAMIDE; DOCOSATETRAENOYL ETHANOLAMIDE; ENDOCANNABINOID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLEOYL ETHANOLAMIDE; OLEOYL ETHANOLAMIDE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITOYL ETHANOLAMIDE; POLYUNSATURATED FATTY ACID; STEAROYL ETHANOLAMIDE; UNCLASSIFIED DRUG; AMIDE;

ADULT; APPETITE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; END STAGE RENAL DISEASE; FATTY ACID BLOOD LEVEL; FEMALE; HEMODIALYSIS PATIENT; HUMAN; LIPID COMPOSITION; MALE; OBSERVATIONAL STUDY; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SATIETY; SIMPLIFIED NUTRITIONAL APPETITE QUESTIONNAIRE; AGED; BLOOD; CHRONIC KIDNEY FAILURE; HEMODIALYSIS; MIDDLE AGED;

ADULT; AGED; APPETITE; CROSS-SECTIONAL STUDIES; ENDOCANNABINOIDS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LINOLEIC ACIDS; MALE; MIDDLE AGED; PILOT PROJECTS; POLYUNSATURATED ALKAMIDES; RENAL DIALYSIS; SURVEYS AND QUESTIONNAIRES;

EID: 84973394989     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2016.03.009     Document Type: Article

References (26)

1. Aguilera A., Selgas R., Codoceo R., Bajo A. Uremic anorexia: A consequence of persistently high brain serotonin levels? the tryptophan/serotonin disorder hypothesis. Perit Dial Int 2000, 20(6):810-816.
2. Carrero J.J., Aguilera A., Stenvinkel P., Gil F., Selgas R., Lindholm B. Appetite disorders in uremia. J Ren Nutr 2008, 18(1):107-113.
3. Bergstrom J. Nutrition and Mortality in hemodialysis. J Am Soc Nephrol 1995, 6(5):1329-1341.
4. Bossola M., Tazza L., Luciani G. Mechanisms and treatment of anorexia in end-stage renal disease patients on hemodialysis. J Ren Nutr 2009, 19(1):2-9.
5. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410(6830):822-825.
6. Di Marzo V., Matias I. Endocannabinoid control of food intake and energy balance. Nat Neurosci 2005, 8(5):585-589.
7. Matias I., Bisogno T., Di Marzo V. Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. Int J Obes (Lond) 2006, 30(Suppl. 1):S7-S12.
8. Kim J., Li Y., Watkins B.A. Endocannabinoid signaling and energy metabolism: a target for dietary intervention. Nutrition 2011, 27(6):624-632.
9. Despres J.P., Golay A., Sjostrom L. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 2005, 353(20):2121-2134.
10. Watkins B.A., Kim J. The endocannabinoid system: directing eating behavior and macronutrient metabolism. Front Psychol 2015, 5.
11. Kim J., Carlson M.E., Watkins B.A. Docosahexaenoyl ethanolamide improves glucose uptake and alters endocannabinoid system gene expression in proliferating and differentiating C2C12 myoblasts. Front Physiol 2014, 5:100.
12. Diep T.A., Madsen A.N., Holst B., Kristiansen M.M., Wellner N., Hansen S.H., et al. Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor. FASEB J 2011, 25(2):765-774.
13. Wilson M.M., Thomas D.R., Rubenstein L.Z., Chibnall J.T., Anderson S., Baxi A. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr 2005, 82(5):1074-1081.
14. Hanisah R., Suzana S., Lee F.S. Validation of screening tools to assess appetite among geriatric patients. J Nutr Health Aging 2012, 16(7):660-665.
15. Salmean Y.A., Zello G.A., Dahl W.J. Foods with added fiber improve stool frequency in individuals with chronic kidney disease with no impact on appetite or overall quality of life. BMC Res Notes 2013, 6:510.
16. Kim J., Carlson M., Kuchel G., Newman J.W., Watkins B.A. Dietary DHA reduces downstream endocannabinoid and inflammatory gene expression and epididymal fat mass while improving aspects of glucose use in muscle in C57BL/6 J mice. Int J Obes 2015, [epub].
17. Li Y., Watkins B.A. Conjugated linoleic acids alter bone fatty acid composition and reduce ex vivo prostaglandin E-2 biosynthesis in rats fed n-6 or n-3 fatty acids. Lipids 1998, 33(4):417-425.
18. Grapov D., Adams S.H., Pedersen T.L., Garvey W.T., Newman J.W. Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. PLoS One 2012, 7(11):e48852.
19. Grapov D., Newman J.W. imDEV: a graphical user interface to R multivariate analysis tools in Microsoft Excel. Bioinformatics 2012, 28(17):2288-2290.
20. Igarashi M., DiPatrizio N.V., Narayanaswami V., Piomelli D. Feeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodents. Biochim Biophys Acta 2015, 1851(9):1218-1226.
21. Sarro-Ramirez A., Sanchez-Lopez D., Tejeda-Padron A., Frias C., Zaldivar-Rae J., Murillo-Rodriquez E. Brain molecules and appetite: the case of oleoylethanolamide. Cent Nerv Syst Agents Med Chem 2013, 13:88-91.
22. Ezzili C., Otrubova K., Boger D.L. Fatty acid amide signaling molecules. Bioorg Med Chem Lett 2010, 20(20):5959-5968.
23. Oleson E.B., Cheer J.F. A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking. Cold Spring Harb Perspect Med 2012, 2(8).
24. Wise R.A. Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond B Biol Sci 2006, 361(1471):1149-1158.
25. Brown I., Cascio M.G., Wahle K.W.J., Smoum R., Mechoulam R., Ross R.A., et al. Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines. Carcinogenesis 2010, 31(9):1584-1591.
26. Friedman A.N., Yu Z.S., Tabbey R., Denski C., Tamez H., Wenger J., et al. Low blood levels of long-chain n-3 polyunsaturated fatty acids in US hemodialysis patients: Clinical Implications. Am J Nephrol 2012, 36(5):451-458.